Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 204-129-5 | CAS number: 116-16-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2015
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: OECD Guideline Study - DRAFT
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- mouse local lymph node assay (LLNA)
- Species:
- mouse
- Strain:
- other: CBA/CaOlaHsd
- Sex:
- female
- Details on test animals and environmental conditions:
- Species/strain: healthy CBA/CaOlaHsd mice
Source: Harlan Laboratories GmbH, 5800 AN Venray, The Netherlands
Sex: female (nulliparous and non-pregnant)
Age at the beginning of the study: 8-9 weeks
Number of animals: 5 mice / group
5 mice / prescreen test
The animals were derived from a controlled full-barrier maintained breeding system (SPF). According to Art. 9.2, No. 7 of the German Act on Animal Welfare the animals are bred for experimental purposes.
Full barrier in an air-conditioned room
Temperature: 22 ± 3 °C
Relative humidity: 55 ± 10%
Artificial light, sequence being 12 hours light, 12 hours dark
Air change: at least 10 x / hour
Free access to Altromin 1324 maintenance diet for rats and mice (prescreen test and main study: lot no. 1239)
Free access to tap water, sulphur acidified to a pH value of approx. 2.8 (drinking water, municipal residue control, microbiological controls at regular intervals)
The animals were kept in groups of 5 animals in IVC cages, type II L, polysulphone cages on Altromin saw fibre bedding (prescreen test and main study: lot no. 02102150227)
Certificates of food, water and bedding are filed for two years at BSL Munich and afterwards archived at Eurofins Munich
Adequate acclimatisation period (at least five days) under laboratory conditions
The animals were randomly selected using the validated departmental computerised system E WorkBook (version 9.4.0, ID Business Solutions Ltd.).
Identification was ensured by cage number and individual marking (tail).
Clinical Observation
Prior to the application and once a day thereafter all animals were observed in order to detect signs of toxicity, including dermal irritation at site of application.
Weight Assessment
The animals were weighed prior to the application and at the end of the test period (prior to the treatment with 3HTdR).
Dose Groups
3 test groups (3 different concentrations) and 1 negative control group (vehicle) were tested. - Vehicle:
- acetone/olive oil (4:1 v/v)
- Concentration:
- 25%, 50% (each diluted with AOO 4:1, v/v) and 100% (undiluted test item)
- No. of animals per dose:
- 5 mice / group
5 mice / prescreen test - Details on study design:
- Topical Application
Immediately before the first application the thickness of both ears of all animals was measured. Each mouse was treated by topical application of 25 µL of the selected solution to the entire dorsal surface of each ear. A second measurement of the ear thickness of all animals was carried out approximately 48 hours after the first application.
Topical applications were performed once daily over three consecutive days.
Administration of 3H-Methyl Thymidine
Five days after the first topical application all mice were dosed with 20 µCi 3H-methyl thymidine by intravenous injection (tail vein) of 250µL of 3H-methyl thymidine, diluted to a working concentration of 80µCi/mL.
Preparation of Cell Suspension
Approximately 5 hours after the injection of 3H-methyl thymidine all mice were sacrificed by cervical dislocation. Shortly before sacrificing the thickness of the ears of all animals was measured for a third time. The draining auricular lymph nodes were excised, individually pooled for each animal (2 lymph nodes per animal) and collected in phosphate buffered saline (PBS). A single cell suspension of pooled lymph node cells was prepared by gentle mechanical disaggregation through polyamide gauze (200 mesh size). After washing the gauze with PBS the cell suspension was pelleted in a centrifuge. The supernatant was discarded and the pellets were resuspended with PBS. This washing procedure was repeated.
After the final wash each pellet was resuspended in approx. 1 mL 5% TCA at approx. 4° C for approximately 18 hours for precipitation of macromolecules. Each precipitate was once washed again, resuspended in 1 mL 5% TCA and 7 mL scintillation fluid was added. Then this solution was transferred into scintillation vials and stored at room temperature overnight.
Determination of Incorporated 3H -Methyl Thymidine
The 3H-methyl thymidine – incorporation was measured in a ß-counter and expressed as the number of disintegrations per minute (DPM). Similarly, background 3H-methyl thymidine levels were also measured (5% TCA). Determination of radioactivity was performed individually for each animal. - Positive control substance(s):
- other: P-Phenylenediamine
- Statistics:
- EC3 values, calculated concentrations which induce stimulation indices of three, are determined by linear interpolation, EC3=c+[(3-d)/(b-d)]x(a c), between two points of the stimulation indices axis, one above (a,b) and one below (c,d) the stimulation index of three. If all measured points are above or below the stimulation index of three, no EC3 value can be stated.
A substance is regarded as a 'sensitiser' in the LLNA if at least one concentration of the test item results in a 3-fold or greater increase in 3H-methyl thymidine - incorporation into lymph node cells of the test group animals, relative to that recorded for the lymph nodes of control group animals (Stimulation Index equal to or greater than 3.0). - Positive control results:
- Stimulation Index of P-Phenylenediamine: 13,2 +/- 2.2
- Parameter:
- SI
- Remarks on result:
- other: see Remark
- Remarks:
- Each of the three tested concentrations of the test item reached the stimulation index of3. The stimulation index at a concentration of 25% was 27.3 The stimulation index at a concentration of 50% was 33.1 The stimulation index at a concentration of 100% was 19.8
- Parameter:
- other: disintegrations per minute (DPM)
- Remarks on result:
- other: see Remark
- Remarks:
- The proliferative response of lymph node cells was expressed as the number of radioactive disintegrations per minute per lymph node (DPM/NODE) and as the ratio of 3H-methyl thymidine - incorporation into lymph node cells of test group animals relative to that recorded for control group animals (STIMULATION INDEX). Before DPM/NODE values were determined, background values were subtracted.
- Interpretation of results:
- Category 1 (skin sensitising) based on GHS criteria
- Remarks:
- Migrated information
- Conclusions:
- Each of the tested concentrations exceeded the stimulation index of 3. The EC3 value could not be calculated due to the lack of a dose-response relationship of the data obtained.
Consequently, according to OECD 429 the test item HEXACHLOROACETONE is expected to be a dermal sensitiser. Therefore, according to Commission Regulation (EU) No 286/2011 as well as GHS (Globally Harmonized Classification System) the test item HEXACHLOROACETONE has obligatory labelling requirement for skin sensitisation and is classified into Category 1. - Executive summary:
Based on the results of the prescreen test the test item was assessed for sensitising properties at concentrations of 25% (v/v), 50% (v/v) , each diluted with AOO 4:1, (v/v) and 100% (undiluted test item).
At the daily clinical observation the animals did not show any visible clinical symptoms and no case of mortality was observed.
Species/strain: Mice, CBA/CaOlaHsd
Number of animals: 20/main test
Vehicle: AOO (4:1 (v/v) acetone/olive oil)
Summary Results
Eachof the three tested concentrations of the test item reached the stimulation index of3.
The stimulation index at a concentrationof 25% was 27.3
The stimulation index at a concentrationof 50% was 33.1
The stimulation index at a concentrationof 100% was 19.8
Classification in sub-category 1A or 1B cannot be made as the EC3 value could not be calculated due to the lack of dose-response relationship of the data obtained. The means of the ear thickness per group showed no relevant difference compared to the negative control.
The mean ear thickness on
day 1
day 3
day 6
for the 25% test group was
0.17 mm
0.18 mm
0.18 mm
for the 50% test group was
0.18 mm
0.18 mm
0.18 mm
for the 100% test group was
0.17 mm
0.18 mm
0.18 mm
for the negative control group was
0.17 mm
0.17 mm
0.17 mm
Conclusion
Each of the tested concentrations exceeded the stimulation index of 3. The EC3 value could not be calculated dueto the lack of a dose-response relationship of the data obtained.
Consequently, according to OECD 429 the test item HEXACHLOROACETONE is expected to be a dermal sensitiser. Therefore, according to Commission Regulation (EU) No 286/2011 as well as GHS (Globally Harmonized Classification System) the test item HEXACHLOROACETONE has obligatory labelling requirement for skin sensitisation and is classified into Category 1.
Reference
Directly prior to the first application, approximately 48 hours after the first application and shortly before excising the lymph nodes the thickness of both ears from all animals was measured.
The means of the ear thickness per group showed no relevant difference compared to the negative control.
The mean ear thickness on |
day 1 |
day 3 |
day 6 |
for the 25% test group was |
0.17 mm |
0.18 mm |
0.18 mm |
for the 50% test group was |
0.18 mm |
0.18 mm |
0.18 mm |
for the 100% test group was |
0.17 mm |
0.18 mm |
0.18 mm |
for the negative control group was |
0.17 mm |
0.17 mm |
0.17 mm |
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (sensitising)
- Additional information:
- Migrated from Short description of key information:
Each of the tested concentrations exceeded the stimulation index of 3. The EC3 value could not be calculated due to the lack of a dose-response relationship of the data obtained.
Consequently, according to OECD 429 the test item HEXACHLOROACETONE is expected to be a dermal sensitiser. Therefore, according to Commission Regulation (EU) No 286/2011 as well as GHS (Globally Harmonized Classification System) the test item HEXACHLOROACETONE has obligatory labelling requirement for skin sensitisation and is classified into Category 1.
Justification for selection of skin sensitisation endpoint:
OECD Guideline Study acc. to OECD 429
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
HEXACHLOROACETONE has obligatory labelling requirement for skin sensitisation and is classified into Category 1.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.